Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROSUVASTATIN\ROSUVASTATIN vs ROZANOLIXIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROSUVASTATIN\ROSUVASTATIN vs ROZANOLIXIZUMAB: Safety Overview

Metric ROSUVASTATIN\ROSUVASTATIN ROZANOLIXIZUMAB
Total FAERS Reports 557 303
Deaths Reported 13 9
Death Rate 2.3% 3.0%
Hospitalizations 170 114
Average Patient Age 65.7 yrs 61.3 yrs
% Female Patients 49.6% 60.9%
Manufacturer N/A UCB, Inc.
Route N/A SUBCUTANEOUS